Clinical Trials List
2024-02-12 - 2030-07-31
Phase II/III
Recruiting6
ICD-10C56.1
Malignant neoplasm of right ovary
ICD-10C56.2
Malignant neoplasm of left ovary
ICD-10C56.9
Malignant neoplasm of unspecified ovary
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9183.0
Malignant neoplasm of ovary
-
Trial Applicant
Daiichi Sankyo Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 吳珮瑩 無
- 梁玉玲 無
- 林語涵 無
- 鄭雅敏 無
- Meng-Ru Shen 無
- Keng-Fu Hsu 無
- Cheng-Yang Chou 無
- 黃蘭茵 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 沈書慧 無
- Mei-Ju Chen 無
- Yi-Jen Chen 無
- Huann-Cheng Horng 無
- 楊思婷 無
- 楊思婷 無
- Yen-Hou Chang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳鵬宇 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ting-Chang Chang 無
- 黃彥綾 無
- Angel Chao 無
- Yun-Hsin Tang 無
- HSIU-JUNG TUNG 無
- 陳威君 無
- 黃寬仁 無
- Chyong-Huey Lai 無
- 李建興 無
- Min-Yu Chen 無
- Huei-Jean Huang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
22 participants
-
Global
860 participants
